Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert

• Main Authors: Eleonora Terreni, Susi Burgalassi, Patrizia Chetoni, Silvia Tampucci, Erica Zucchetti, Roberta Fais, Emilia Ghelardi, Antonella Lupetti, Daniela Monti
• Format: Article
• Language: English
• Published: MDPI AG 2020-04-01
• Series: Biomolecules
• Subjects: hLF 1-11; freeze-drying; ocular insert; peptide; antimicrobial activity; AMPs
• Online Access: https://www.mdpi.com/2218-273X/10/5/664

Infectious ocular keratitis is the leading cause of blindness worldwide. Bacterial resistance to classical pharmacological treatments raised the interest of researchers towards antimicrobial peptide (AMP)-based therapy. hLF 1-11, a synthetic antimicrobial peptide derived from the N-terminus of human lactoferrin, proved effective against different bacteria and yeast but, like all proteinaceous materials, it is unstable from chemical, physical, and biological points of view. In this study, new freeze-dried solid matrices containing mucoadhesive polymers were prepared and characterized in terms of rheology, hydration time, bioadhesion, drug content, and in vitro release. The formulation HPMC/T2/HA/hLF 1-11_fd was selected for the delivery of hLF 1-11, since it showed good drug recovery and no chemical degradation up to at least 6 months (long-term stability). Furthermore, the HPMC/T2/HA/hLF 1-11_fd matrix allowed for the release of the drug in a simulated physiological environment, linked to an optimal hydration time, and the peptide antimicrobial activity was preserved for up to 15 months of storage, a very promising result considering the chemical liability of proteinaceous material. For its properties, the freeze-dried matrix developed in this study could be a good platform for the delivery of antimicrobial peptides in the precorneal area to treat infectious phenomena of the ocular surface.